When, which and how to switch: Navigating JAK inhibitors in myelofibrosis.
Saved in:
| Title: | When, which and how to switch: Navigating JAK inhibitors in myelofibrosis. |
|---|---|
| Authors: | O'Sullivan J; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Omerdeen I; New College Oxford and Oxford University Medical School, Oxford, UK., Psaila B; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.; Department of Haematology, Oxford University NHS Trust, Oxford, UK.; Oxford Ludwig Cancer Institute, Oxford, UK. |
| Source: | British journal of haematology [Br J Haematol] 2026 Feb; Vol. 208 (2), pp. 437-441. Date of Electronic Publication: 2024 Nov 27. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
